The company usually posts poor financials for mid or long term investments.
The company has poor fundamentals for a short-term investment strategy.
The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at USD 315.78 USD in weekly data.
Its core activity has a significant growth potential and sales are expected to surge, according to Thomson Reuters' forecast. Indeed, those may increase by 58% by 2019.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The group usually releases earnings worse than estimated.
With an enterprise value anticipated at 3.59 times the sales for the current fiscal year, the company turns out to be overvalued.
With an expected P/E ratio at 125.8 and 57.83 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
For the past year, analysts have significantly revised downwards their profit estimates.